A Multi-Center Trial to Compare Three Doses of Meloxicam and Placebo in Patients With Rheumatoid Arthritis

PHASE3CompletedINTERVENTIONAL
Enrollment

1,000

Participants

Timeline

Start Date

June 30, 2002

Study Completion Date

July 31, 2003

Conditions
Arthritis, Rheumatoid
Interventions
DRUG

Meloxicam

Trial Locations (153)

105

Chang Gung Memorial Hospital, Taipei

1027

National Institute for Rheumatology and Physiotherapy, Budapest

1040

Clinique du Parc Léopold, Brussels

1405

Boehringer Ingelheim Investigational Site, Buenos Aires

1427

Boehringer Ingelheim Investigational Site, Buenos Aires

1428

Boehringer Ingelheim Investigational Site, Buenos Aires

2000

Boehringer Ingelheim Investigational Site, Rosario

3000

Medisch Centrum van Huisartsen, Leuven

3144

Emeritus Research, Malvern

3501

St. Ferenc Hospital, Miskolc

3601

Pál Almási Balogh Hospital, Ózd

4031

DOTE, Debrecen

4558

Boehringer Ingelheim Investigational Site, Cotton Tree

6004

Department of Rheumatology, Perth

6720

Szegedi University, Szeged

7621

Hungarian Brothers of St. John of Good, Pécs

8201

Ferenc Csolnoky County Hospital, Veszprém

8380

St. Andrew State Hospital, Hévíz

9024

Aladár Petz County Hospital, Győr

10021

Boehringer Ingelheim Investigational Site, New York

13008

Boehringer Ingelheim Investigational Site, Marseille

14059

Rheumatologie und Physikalische Therapie, Berlin

16635

Altoona Center for Clinical Research, Duncansville

17011

Boehringer Ingelheim Investigational Site, Camp Hill

17055

Suite D, Mechanicsburg

20006

Suite 300, Washington D.C.

20902

Suite 306, Wheaton

22044

Suite 2A, Falls Church

23795

Boehringer Ingelheim Investigational Site, Bad Segeberg

28210

Suite 100, Charlotte

29118

Boehringer Ingelheim Investigational Site, Orangeburg

29204

Boehringer Ingelheim Investigational Site, Columbia

29406

Suite H, North Charleston

32204

Boehringer Ingelheim Investigational Site, Jacksonville

32607

Boehringer Ingelheim Investigational Site, Gainsville

32804

Boehringer Ingelheim Investigational Site, Orlando

32806

Suite 2, Orlando

33143

Boehringer Ingelheim Investigational Site, South Miami

33173

Suite 202, Miami

33484

Boehringer Ingelheim Investigational Site, Delray Beach

33540

Boehringer Ingelheim Investigational Site, Zephyrhills

33614

Suite 203, Tampa

33710

Suite 101, St. Petersburg

33773

Boehringer Ingelheim Investigational Site, Largo

34239

Boehringer Ingelheim Investigational Site, Sarasota

34471

Renstar Medical Research, Ocala

34695

Suite 406, Safety Harbor

34996

Radiant Research, Stuart

35801

Suites 570 (research) & 600 (PI), Huntsville

36106

Suite 200, Montgomery

37000

Boehringer Ingelheim Investigational Site, Tours

37044

Boehringer Ingelheim Investigational Site, Tours

43214

Boehringer Ingelheim Investigational Site, Columbus

45356

Elisabeth-Krankenhaus, Essen

46202

Boehringer Ingelheim Investigational Site, Indianapolis

49009

Suite 202, Kalamazoo

49044

Dnyepropyetrovsk Medical Academy, Dnyepropetrovsk

52064

Boehringer Ingelheim Investigational Site, Aachen

55543

Augusta-Klinik, Bad Kreuznach

56818

Boehringer Ingelheim Investigational Site, Klotten

60035

Ospedale Augusto Murri, Iesi

60045

Boehringer Ingelheim Investigational Site, Lake Forest

61091

Municipal Institute of Health Care, Kharkiv

61103

Boehringer Ingelheim Investigational Site, Rockford

61115

City Multitype Clinical Hospital No. 25, Kharkiv

62704

Boehringer Ingelheim Investigational Site, Springfield

63128

Suite 101, St Louis

63141

Suite 240, St Louis

65191

Klinik für Rheumatologie,, Wiesbaden

67207

Attn: Kathy Stoddard, Director, Wichita

68506

Boehringer Ingelheim Investigational Site, Lincoln

72070

Boehringer Ingelheim Investigational Site, Tübingen

73016

Ospedale A. Galateo, SAN Cesario (Lecce)

74135

Boehringer Ingelheim Investigational Site, Tulsa

75225

Boehringer Ingelheim Investigational Site, Dallas

75231

Radiant Research, Dallas

78217

Suites 207, San Antonio

78705

Boehringer Ingelheim Investigational Site, Austin

79410

Suite 500, Lubbock

80131

"Università degli Studi di Napoli Federico II", Napoli

80910

Suite 200, Colorado Springs

81541

Boehringer Ingelheim Investigational Site, München

83098

Central City Hospital, Donetsk

83114

State Medical University, Donetsk

83404

Suite 202, Idaho Falls

85012

Suite 601, Phoenix

85015

Suite 201, Phoenix

85308

#106, Glendale

85643

Boehringer Ingelheim Investigational Site, Steinhöring

90048

Boehringer Ingelheim Investigational Site, Los Angeles

90402

Boehringer Ingelheim Investigational Site, Nuremberg

90461

Boehringer Ingelheim Investigational Site, Nuremberg

91105

Boehringer Ingelheim Investigational Site, Pasadena

91361

Westlake Medical Research, Westlake Village

91730

Suite 100, Rancho Cucamonga

92108

Suite 208, San Diego

92120

Suite 202, San Diego

93454

Suite A, Santa Maria

94578

Suite 301, San Leandro

98201

Boehringer Ingelheim Investigational Site, Everett

98902

Boehringer Ingelheim Investigational Site, Yakima

99508

Suite 140, Anchorage

115522

Institute of Rheumatology of RAMN, Moscow

117049

City Clinical Hospital No. 1, Moscow

92270-4469

Boehringer Ingelheim Investigational Site, Rancho Mirage

06810

Suites 205 & 206, Danbury

03474

Boehringer Ingelheim Investigational Site, Ocala

83814-2644

Boehringer Ingelheim Investigational Site, Coeur d'Alene

02720

Truesdale Clinic, Fall River

89502-1196

Boehringer Ingelheim Investigational Site, Reno

08055

PC, Jackson Commons D-2, Medford

08619

Suite 8, Mercerville

16508-1256

Boehringer Ingelheim Investigational Site, Erie

02919

Suite 331-333, Johnston

75246-1632

Suite 200, Dallas

98166-2967

Suite D-3, Seattle

74043-011

Av Anhanguera 6479, Goiânia GO

90035-003

Rua Ramiro Barcelos 2350, Porto Alegre RS

04040-000

Boehringer Ingelheim Investigational Site, São Paulo - SP

04230-000

Clínica de Doenças Parasitárias e Infecciosas-Hospital Dia, São Paulo - SP

V7C 5L9

230-6091, Richmond

V8P 5P6

Boehringer Ingelheim Investigational Site, Victoria

N0N 1G0

Boehringer Ingelheim Investigational Site, Corunna

L2A 1Z3

Boehringer Ingelheim Investigational Site, Fort Erie

L8N 1Y2

Boehringer Ingelheim Investigational Site, Hamilton

K7L 2V6

Dr. Denis O'Donnell, Kingston

L5B 4A2

Trillium Health Centre, Mississauga

K2P 1V3

Boehringer Ingelheim Investigational Site, Ottawa

K9J 7H8

Boehringer Ingelheim Investigational Site, Peterborough

N7T 4X3

Boehringer Ingelheim Investigational Site, Sarnia

M1B 4Y9

Boehringer Ingelheim Investigational Site, Scarborough Village

L2N 4H4

104-532, St. Catharines

M3B 2H9

Boehringer Ingelheim Investigational Site, Toronto

N8W 5L7

Boehringer Ingelheim Investigational Site, Windsor

H3G 1A4

Boehringer Ingelheim Investigational Site, Montreal

H3Z, 2Z3

Boehringer Ingelheim Investigational Site, Montreal

H9R 3J1

Boehringer Ingelheim Investigational Site, Pointe-Claire

06000

Boehringer Ingelheim Investigational Site, Nice

08236

Boehringer Ingelheim Investigational Site, Ellefeld

04229

ClinPharm International GmbH & Co. KG, Leipzig

Unknown

Università degli Studi, Genova

Kaohsiung Medical University Chung-Ho Memorial Hospital, Kaohsiung City

Rheumatology-Allergy-Immunology, Kaohsiung City

Taipei Veterans General Hospital, Taipei

431-070

896 Pyung Chon-Dong, Dongan-Gu, Gyeonggi-do

442-721

San-5, Woncheon-Dong, Paldal-Gu, Gyeonggi-do

100-032

85 Jeo-Dong 2Ga, Seoul

110-744

Seoul National University Hospital, Seoul

120-752

Boehringer Ingelheim Investigational Site, Seoul

01023

Central Clinical Hospital, Kiev

03151

Institute of Cardiology, Kiev

04107

Regional Hospital No. 1, Kiev

04114

Institute of Gerontology, Kyiv

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY

NCT00042068 - A Multi-Center Trial to Compare Three Doses of Meloxicam and Placebo in Patients With Rheumatoid Arthritis | Biotech Hunter | Biotech Hunter